ALVAC-hB7.1

BIOLOGICAL2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Melanoma (Skin)Recurrent Ovarian Epithelial Cancer

Phase 1

Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer

CompletedNCT00004032

National Cancer Institute (NCI)Recurrent Ovarian Epithelial Cancer

Start: 1997-10-31Updated: 2013-01-23

Vaccine Therapy in Treating Patients With Melanoma

CompletedNCT00003556

National Cancer Institute (NCI)Melanoma (Skin)

Start: 1999-01-31Updated: 2013-02-08